Roche Holding AG logo

Roche Holding AG

ROG.SW
HealthcareSIXSwitzerland
322.30CHF+1.60 (+0.50%)

About Roche

Roche Holding AG operates in the pharmaceuticals and diagnostics industries, serving a global market that includes Switzerland, Germany, the United States, and various other countries.

The company is divided into two main business segments:

  • Pharmaceuticals: This segment focuses on developing and marketing drugs for a range of medical conditions, including oncology, neuroscience, infectious diseases, immunology, cardiovascular and metabolic disorders, ophthalmology, and respiratory issues. It also covers treatments for anemia, cancer, dermatology, hemophilia, inflammatory and autoimmune diseases, neurological conditions, and organ transplantation.

  • Diagnostics: Roche provides in vitro diagnostic tests used for detecting a variety of health conditions, including cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and others. The company also supplies the necessary diagnostic instruments and reagents for these tests.

Founded in 1896, Roche Holding AG is headquartered in Basel, Switzerland.

Roche's Business Strategy

​Roche operates a unique business model that integrates pharmaceuticals and diagnostics to advance personalized healthcare. This dual approach enables Roche to provide comprehensive solutions spanning disease prevention, diagnosis, treatment, and monitoring, thereby enhancing patient outcomes and healthcare efficiency. ​

In its Pharmaceuticals division, Roche focuses on…

Available on Finplify

Free account required

Sign up free

Our Take on Roche

Pros:

Oncology & Diagnostics Leadership: Roche is a pharmaceutical and diagnostics giant, best known for its dominance in oncology, immunology, and molecular diagnostics.

Biologics & Immunotherapy Strong Pipeline: Roche has a deep and advancing R&D pipeline, particularly in next-generation cancer therapies, rare diseases, and…

Available on Finplify

Free account required

Sign up free

Company Details

Exchange
SIX
Country
Switzerland
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Thomas Schinecker
Employees
103,249
IPO Date
1995-08-03
ISIN
CH0012032048
Website
roche.com

Key Metrics

Market Cap
256.55BCHF
P/E Ratio (TTM)
18.78
Net Profit Margin
20.94%
Debt / Asset Ratio
0.31
Dividend Yield (TTM)
3.22%
Volume
778,976
Avg Volume
1.09M
Shares Outstanding
796.00M
Free Float
86.55%
β Beta
0.20
52W Range
231.9 - 374.9

Fundamental Analysis

Proprietary 5-category scoring system

Score Fingerprint

Section Scores

Profitability
4.8/5Excellent
Liquidity
3.2/5Average
Leverage
4.0/5Good
Cash Flow
4.5/5Excellent
Valuation
3.9/5Good

Full Breakdown & Peer Ranking

See the detailed score for every metric and how this stock ranks against its sector peers

Unlock for free
Free to join

Unlock the full research on Roche

Get the full fundamental score breakdown, business strategy, our investment take, live charts and AI-powered briefings. All in one ad-free workspace.

300+ Curated Stocks

A hand-picked universe of world-class businesses across every major market and sector.

AI Analyst Briefings

Deploy your own AI analyst that monitors your portfolio and delivers daily intelligence reports.

Proprietary Fundamentals

Five-category scoring for every stock — profitability, liquidity, leverage, cash flow, and valuation.